Grants per year
Personal profile
Education/Academic qualification
Cancer Biology, PhD, University of Texas, MD Anderson Cancer Center
… → 2005
Medicine, MD, Russian State Medical University
… → 1999
Fingerprint
Dive into the research topics where Yanis Boumber is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
4/1/20 → 3/31/23
Project: Research project
-
Prot #C-145-03: A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145) for the Treatment of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Chiltern International, Inc., Iovance Biotherapeutics, Inc.
2/23/18 → 2/23/23
Project: Research project
-
Prot #MK-3475-122: A Two-Arm, Open-label, Randomized Phase II Study of Pembrolizumab (MK-3475) Monotherapy Versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122)
Boumber, Y. & Matsangou, M.
Merck Sharp & Dohme Corporation
1/26/17 → 1/31/25
Project: Research project
-
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
Khabibov, M., Garifullin, A., Boumber, Y., Khaddour, K., Fernandez, M., Khamitov, F., Khalikova, L., Kuznetsova, N., Kit, O. & Kharin, L., Jun 2022, In: International journal of oncology. 60, 6, 69.Research output: Contribution to journal › Article › peer-review
Open Access -
Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents
Gusakov, E. A., Topchu, I. A., Mazitova, A. M., Dorogan, I. V., Bulatov, E. R., Serebriiskii, I. G., Abramova, Z. I., Tupaeva, I. O., Demidov, O. P., Toan, D. N., Lam, T. D., Bang, D. N., Boumber, Y. A., Sayapin, Y. A. & Minkin, V. I., Jan 22 2021, In: RSC Advances. 11, 8, p. 4555-4571 17 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
Topchu, I., Karnaukhov, N., Mazitova, A., Yugai, V., Voloshin, M., Tikhomirova, M., Kit, O., Frantsiyants, E., Kharin, L., Airapetova, T., Ratner, E., Sabirov, A., Abramova, Z., Serebriiskii, I., Boumber, Y. & Deneka, A., Mar 2021, In: Journal of Thoracic Disease. 13, 3, p. 1370-1379 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
Makhov, P., Bychkov, I., Faezov, B., Deneka, A., Kudinov, A., Nicolas, E., Brebion, R., Avril, E., Cai, K. Q., Kharin, L. V., Voloshin, M., Frantsiyants, E., Karnaukhov, N., Kit, O. I., Topchu, I., Fazliyeva, R., Nikonova, A. S., Serebriiskii, I. G., Borghaei, H., Edelman, M. & 3 others, , Mar 2021, In: Oncogenesis. 10, 3, 29.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression
Kharin, L., Bychkov, I., Karnaukhov, N., Voloshin, M., Fazliyeva, R., Deneka, A., Frantsiyants, E., Kit, O., Golemis, E. & Boumber, Y., Jul 2021, In: PloS one. 16, 7 July, e0252132.Research output: Contribution to journal › Article › peer-review
Open Access